Free Trial
LON:TSTL

Tristel (TSTL) Share Price, News & Analysis

Tristel logo
GBX 350 0.00 (0.00%)
As of 04/25/2025 12:28 PM Eastern

About Tristel Stock (LON:TSTL)

Key Stats

Today's Range
335
360
50-Day Range
268.30
355
52-Week Range
260
572.50
Volume
222,892 shs
Average Volume
112,770 shs
Market Capitalization
£167.20 million
P/E Ratio
25.61
Dividend Yield
3.71%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com

Receive TSTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tristel and its competitors with MarketBeat's FREE daily newsletter.

TSTL Stock News Headlines

Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
See More Headlines

TSTL Stock Analysis - Frequently Asked Questions

Tristel's stock was trading at GBX 421.60 at the beginning of the year. Since then, TSTL stock has decreased by 17.0% and is now trading at GBX 350.
View the best growth stocks for 2025 here
.

Tristel plc (LON:TSTL) announced its earnings results on Monday, February, 24th. The company reported $8.17 earnings per share for the quarter. Tristel had a trailing twelve-month return on equity of 20.43% and a net margin of 15.47%.

Shares of TSTL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tristel investors own include Standard Life Aberdeen (SL), Barclays (BARC), BP (BP), Capital One Financial (COF), Lloyds Banking Group (LLOY), Automatic Data Processing (ADP) and Ashtead Group (AHT).

Company Calendar

Last Earnings
2/24/2025
Record date for 4/11 Dividend
3/20/2025
Ex-Dividend for 4/11 Dividend
3/20/2025
Dividend Payable
4/11/2025
Today
4/26/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
LON:TSTL
CIK
N/A
Fax
N/A
Employees
208
Year Founded
N/A

Profitability

Trailing P/E Ratio
25.61
Forward P/E Ratio
21.48
P/E Growth
N/A
Net Income
£6.54 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£42.24 million
Cash Flow
GBX 16.70 per share
Price / Cash Flow
20.96
Book Value
GBX 68.34 per share
Price / Book
5.12

Miscellaneous

Free Float
N/A
Market Cap
£167.20 million
Optionable
Not Optionable
Beta
0.23
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (LON:TSTL) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners